{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:49:36Z","timestamp":1782452976707,"version":"3.54.5"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>\n                    This study aimed to evaluate, through a systematic review and meta-analysis of randomized controlled trials (RCTs), the effects of hesperidin and hesperidin-containing citrus interventions on biomarkers of inflammation, oxidative stress, and endothelial function in overweight or obese individuals. Two authors independently searched PubMed, Web of Science, Embase, Scopus, and the Cochrane Library from inception to April 4, 2026. Methodological quality was assessed using the Cochrane Risk of Bias 2 tool (RoB 2), and certainty of evidence was evaluated with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Heterogeneity was assessed using Cochran's\n                    <jats:italic>Q<\/jats:italic>\n                    test and the\n                    <jats:italic>I<\/jats:italic>\n                    -square (\n                    <jats:italic>I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    ) statistic, and fixed- or random-effects models were applied as appropriate. Most continuous outcomes were pooled as mean differences (MDs) with 95% confidence intervals (CIs), whereas total antioxidant capacity (TAC) was pooled as standardized mean differences (SMDs; Hedges'\n                    <jats:italic>g<\/jats:italic>\n                    ) due to inconsistent assay methods. Sixteen RCTs involving 845 participants were included. Compared with placebo or control, hesperidin-related interventions reduced C-reactive protein\/high-sensitivity C-reactive protein (CRP\/hsCRP) (MD: \u22120.43 mg\/L, 95% CI: \u22120.68, \u22120.17,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.001; GRADE = moderate), tumor necrosis factor-alpha (TNF-\u03b1) (MD: \u22122.84 pg\/mL, 95% CI: \u22124.81, \u22120.86,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.005; GRADE = very low), and vascular cell adhesion molecule-1 (VCAM-1) (MD: \u221227.16 ng\/mL, 95% CI: \u221250.13, \u22124.19,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.020; GRADE = very low), with no significant effects on interleukin-6 (IL-6), TAC, or intercellular adhesion molecule-1 (ICAM-1). Malondialdehyde (MDA) and superoxide dismutase (SOD) were reported narratively in single studies. Current randomized evidence suggests that hesperidin-related interventions are associated with a modest reduction in CRP\/hsCRP, representing the most consistent biomarker signal to date. Evidence for TNF-\u03b1 and VCAM-1 remains very low in certainty, and findings for IL-6, oxidative stress markers, and ICAM-1 remain inconclusive. Marked between-study differences in intervention matrix, design structure, and reporting methods preclude dose- or matrix-specific recommendations at present. Further high-quality randomized trials with longer follow-up, standardized biomarker assessment, and better characterization of formulations are needed.\n                  <\/jats:p>","DOI":"10.3389\/fnut.2026.1871474","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:44:04Z","timestamp":1782452644000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of hesperidin supplementation on inflammation and oxidative stress in overweight or obese individuals: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"13","author":[{"given":"Kun","family":"Zhu","sequence":"first","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liao","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Guo","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingwei","family":"Huang","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degui","family":"Chang","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"You","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/oby.24358","article-title":"Projecting global trends and inequalities in adult overweight and obesity, 2023-2040: findings from the NCD-RisC database","volume":"33","author":"Liu","year":"2025","journal-title":"Obesity ."},{"key":"B2","doi-asserted-by":"publisher","first-page":"100375","DOI":"10.1016\/j.metop.2025.100375","article-title":"Obesity: prevalence, causes, consequences, management, preventive strategies and future research directions","volume":"27","author":"Ahmed","year":"2025","journal-title":"Metabol Open."},{"key":"B3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3892\/mmr.2024.13219","article-title":"Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation-mediating treatment options (Review)","volume":"29","author":"Varra","year":"2024","journal-title":"Mol Med Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/ijms27010535","article-title":"Inflammation and resolution in obesity-related cardiovascular disease","volume":"27","author":"Karakasis","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1425168","DOI":"10.3389\/fimmu.2024.1425168","article-title":"C-reactive protein: structure, function, regulation, and role in clinical diseases","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1237729","DOI":"10.3389\/fimmu.2023.1237729","article-title":"C-reactive protein: a target for therapy to reduce inflammation","volume":"14","author":"Rizo-T\u00e9llez","year":"2023","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3390\/nu14061137","article-title":"Anti-inflammatory nutrients and obesity-associated metabolic-inflammation: state of the art and future direction","volume":"14","author":"Grosso","year":"2022","journal-title":"Nutrients"},{"key":"B10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/molecules26040985","article-title":"Antioxidant and Anti-inflammatory potential of polyphenols contained in mediterranean diet in obesity: molecular mechanisms","volume":"26","author":"Nani","year":"2021","journal-title":"Molecules"},{"key":"B11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/10408398.2014.906382","article-title":"Health-promoting effects of the citrus flavanone hesperidin","volume":"57","author":"Li","year":"2017","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.2174\/0929867324666170718104412","article-title":"Potential anti-inflammatory effects of hesperidin from the genus citrus","volume":"25","author":"Tejada","year":"2018","journal-title":"Curr Med Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.17179\/excli2023-6577","article-title":"Promising influences of hesperidin and hesperetin against diabetes and its complications: a systematic review of molecular, cellular, and metabolic effects","volume":"22","author":"Mirzaei","year":"2023","journal-title":"EXCLI J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"106206","DOI":"10.1016\/j.fitote.2024.106206","article-title":"Comprehensive review of Hesperetin: advancements in pharmacokinetics, pharmacological effects, and novel formulations","volume":"179","author":"Song","year":"2024","journal-title":"Fitoterapia."},{"key":"B15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/17425247.2025.2581839","article-title":"Drug delivery and formulation development of hesperidin: a systematic review","volume":"23","author":"Hoang","year":"2026","journal-title":"Expert Opin Drug Deliv."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cbi.2019.04.016","article-title":"The effect of hesperidin supplementation on inflammatory markers in human adults: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"307","author":"Lorzadeh","year":"2019","journal-title":"Chem Biol Interact."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1080\/09603123.2022.2093841","article-title":"Effects of hesperidin on anti-inflammatory and antioxidant response in healthy people: a meta-analysis and meta-regression","volume":"33","author":"Buzdagli","year":"2023","journal-title":"Int J Environ Health Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0007114526106898","article-title":"The effects of hesperidin supplementation on inflammation and oxidative stress in adults: a systematic review and meta-analysis","author":"Ouyang","year":"2026","journal-title":"Br J Nutr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1093\/nutrit\/nuae084","article-title":"Effects of hesperidin supplementation on cardiometabolic markers: a systematic review and meta-analysis of randomized controlled trials","volume":"83","author":"Heidari","year":"2025","journal-title":"Nutr Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/advances\/nmab101","article-title":"Effects of 100% orange juice on markers of inflammation and oxidation in healthy and at-risk adult populations: a scoping review, systematic review, and meta-analysis","volume":"13","author":"Cara","year":"2022","journal-title":"Adv Nutr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B22","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B23","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ."},{"key":"B24","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"B25","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ."},{"key":"B26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"J Clin Epidemiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"Int J Epidemiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12874-018-0483-0","article-title":"Dealing with missing standard deviation and mean values in meta-analysis of continuous outcomes: a systematic review","volume":"18","author":"Weir","year":"2018","journal-title":"BMC Med Res Methodol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1002\/sim.6908","article-title":"Meta-analysis with missing study-level sample variance data","volume":"35","author":"Chowdhry","year":"2016","journal-title":"Stat Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics."},{"key":"B35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ."},{"key":"B36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics."},{"key":"B37","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1152\/physiol.00021.2024","article-title":"Low-grade chronic inflammation: a shared mechanism for chronic diseases","volume":"40","author":"Cifuentes","year":"2025","journal-title":"Physiology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1759720X18783894","article-title":"Inflammation, obesity and rheumatic disease: common mechanistic links. A narrative review","volume":"10","author":"Nikiphorou","year":"2018","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-022-01149-x","article-title":"Signaling pathways in obesity: mechanisms and therapeutic interventions","volume":"7","author":"Wen","year":"2022","journal-title":"Signal Transduct Target Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Emerging Risk Factors","year":"2010","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation."},{"key":"B45","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","article-title":"ELISA and multiplex technologies for cytokine measurement in inflammation and aging research","volume":"63","author":"Leng","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.aca.2014.10.009","article-title":"Bioanalytical chemistry of cytokines\u2013a review","volume":"853","author":"Stenken","year":"2015","journal-title":"Anal Chim Acta."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1093\/eurheartj\/ehaa160","article-title":"Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the cardiovascular inflammation reduction trial","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur Heart J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e005077","DOI":"10.1161\/JAHA.116.005077","article-title":"Inflammatory biomarkers interleukin-6 and C-reactive protein and outcomes in stable coronary heart disease: experiences from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) trial","volume":"6","author":"Held","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2023.05.009","article-title":"Anthocyanin supplementation improves obesity-related inflammatory characteristics: a systematic review and meta-analysis of randomized controlled trials","volume":"116","author":"Song","year":"2023","journal-title":"Nutr Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-3-031-63657-8_10","article-title":"Reappraisal of adipose tissue inflammation in obesity","volume":"1460","author":"Engin","year":"2024","journal-title":"Adv Exp Med Biol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/1389450120666190821161259","article-title":"TNF-\u03b1 and IL-6: the link between immune and bone system","volume":"21","author":"Wang","year":"2020","journal-title":"Curr Drug Targets."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1002\/ptr.7047","article-title":"The effect of soy isoflavones and soy isoflavones plus soy protein on serum concentration of tumor necrosis factor-\u03b1 a systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Hariri","year":"2021","journal-title":"Phytother Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3945\/ajcn.114.104364","article-title":"Orange juice-derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease","volume":"101","author":"Sch\u00e4r","year":"2015","journal-title":"Am J Clin Nutr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1002\/mnfr.201600315","article-title":"Urinary excretion of Citrus flavanones and their major catabolites after consumption of fresh oranges and pasteurized orange juice: a randomized cross-over study","volume":"60","author":"Aschoff","year":"2016","journal-title":"Mol Nutr Food Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.3390\/nu14122481","article-title":"Hesperidin bioavailability is increased by the presence of 2S-diastereoisomer and micronization-a randomized, crossover and double-blind clinical trial","volume":"14","author":"Crescenti","year":"2022","journal-title":"Nutrients"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0304961","DOI":"10.1371\/journal.pone.0304961","article-title":"Within-subject variation of C-reactive protein and high-sensitivity C-reactive protein: a systematic review and meta-analysis","volume":"19","author":"Gough","year":"2024","journal-title":"PLoS ONE."},{"key":"B57","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.3390\/ijms241310978","article-title":"Total antioxidant capacity: biochemical aspects and clinical significance","volume":"24","author":"Silvestrini","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15171\/bi.2015.20","article-title":"Reliability of malondialdehyde as a biomarker of oxidative stress in psychological disorders","volume":"5","author":"Khoubnasabjafari","year":"2015","journal-title":"Bioimpacts."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","article-title":"Statistics notes: analysing controlled trials with baseline and follow up measurements","volume":"323","author":"Vickers","year":"2001","journal-title":"BMJ."},{"key":"B60","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/jrsm.1196","article-title":"Impact of analysing continuous outcomes using final values, change scores and analysis of covariance on the performance of meta-analytic methods: a simulation study","volume":"7","author":"McKenzie","year":"2016","journal-title":"Res Synth Methods."},{"key":"B61","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jclinepi.2016.01.034","article-title":"Change score or follow-up score? Choice of mean difference estimates could impact meta-analysis conclusions","volume":"76","author":"Fu","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408398.2025.2584454","article-title":"Nanotechnology-enhanced delivery systems for bioactive citrus compounds: a comprehensive review","volume":"66","author":"Davodabadi","year":"2025","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/10408398.2021.1961676","article-title":"Recent developments in citrus bioflavonoid encapsulation to reinforce controlled antioxidant delivery and generate therapeutic uses: review","volume":"63","author":"Dadwal","year":"2023","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B64","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1479-5876-9-173","article-title":"Multiplex serum biomarker assessments: technical and biostatistical issues","volume":"9","author":"Butterfield","year":"2011","journal-title":"J Transl Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e2000473","DOI":"10.1002\/mnfr.202000473","article-title":"The effect of plant derived bioactive compounds on inflammation: a systematic review and meta-analysis","volume":"64","author":"Poulsen","year":"2020","journal-title":"Mol Nutr Food Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1024120","DOI":"10.3389\/fimmu.2023.1024120","article-title":"Efficacy and safety of dietary polyphenols in rheumatoid arthritis: a systematic review and meta-analysis of 47 randomized controlled trials","volume":"14","author":"Long","year":"2023","journal-title":"Front Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12013-022-01089-x","article-title":"Regulation of conformational changes in C-reactive protein alters its bioactivity","volume":"80","author":"Ullah","year":"2022","journal-title":"Cell Biochem Biophys."},{"key":"B68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3945\/ajcn.111.031088","article-title":"Effects of red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased cardiovascular risk","volume":"95","author":"Buscemi","year":"2012","journal-title":"Am J Clin Nutr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/ptr.6406","article-title":"Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial","volume":"33","author":"Cheraghpour","year":"2019","journal-title":"Phytother Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.clnu.2014.12.016","article-title":"Marked antioxidant effect of orange juice intake and its phytomicronutrients in mild hypercholesterolemic men: a preliminary randomized crossover trial","volume":"34","author":"Constans","year":"2015","journal-title":"Clin Nutr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/ptr.6046","article-title":"Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial","volume":"32","author":"Homayouni","year":"2018","journal-title":"Phytother Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1093\/jn\/nxaa158","article-title":"Blood orange juice consumption increases flow-mediated dilation in adults with overweight and obesity: a randomized controlled trial","volume":"150","author":"Li","year":"2020","journal-title":"J Nutr"},{"key":"B73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3945\/ajcn.110.004945","article-title":"Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers","volume":"93","author":"Morand","year":"2011","journal-title":"Am J Clin Nutr."},{"key":"B74","doi-asserted-by":"publisher","first-page":"116759","DOI":"10.1016\/j.foodres.2025.116759","article-title":"Effects of a flavonoid-enriched orange juice on antioxidant capacity, lipid profile, and inflammation in obese patients: a randomized placebo-controlled trial","volume":"217","author":"Navajas-Porras","year":"2025","journal-title":"Food Res Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.3390\/nu16183191","article-title":"Daily orange consumption reduces hepatic steatosis prevalence in patients with metabolic dysfunction-associated steatotic liver disease: exploratory outcomes of a randomized clinical trial","volume":"16","author":"Notarnicola","year":"2024","journal-title":"Nutrients"},{"key":"B76","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.jnim.2019.100101","article-title":"Orange juice associated with a balanced diet mitigated risk factors of metabolic syndrome: a randomized controlled trial","volume":"17","author":"Ponce","year":"2019","journal-title":"J Nutr Intermed Metab."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3945\/jn.115.213660","article-title":"Normal or high polyphenol concentration in orange juice affects antioxidant activity, blood pressure and body weight in overweight or obese adults","volume":"145","author":"Rangel-Huerta","year":"2015","journal-title":"J Nutr"},{"key":"B78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nut.2016.12.020","article-title":"Orange juice allied to a reduced-calorie diet results in weight loss and improves obesity-related biomarkers: a randomized controlled trial","volume":"38","author":"Ribeiro","year":"2017","journal-title":"Nutrition"},{"key":"B79","doi-asserted-by":"publisher","first-page":"E782","DOI":"10.1210\/jc.2010-2879","article-title":"Citrus polyphenol hesperidin stimulates production of nitric oxide and improves endothelial function while reducing inflammatory markers in patients with metabolic syndrome","volume":"96","author":"Rizza","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3945\/ajcn.116.136960","article-title":"Randomized clinical trial on the efficacy of hesperidin 2S on validated cardiovascular biomarkers in healthy overweight individuals","volume":"104","author":"Salden","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1039\/c6fo00039h","article-title":"Orange juice consumption and its effect on blood lipid profile and indices of the metabolic syndrome; a randomised, controlled trial in an at-risk population","volume":"7","author":"Simpson","year":"2016"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00394-019-02105-2","article-title":"The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial","volume":"59","author":"Yari","year":"2020","journal-title":"Eur J Nutr"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/s41430-020-0679-3","article-title":"Flaxseed and hesperidin effects on non-alcoholic fatty liver disease: an open-labelled randomized controlled trial","volume":"74","author":"Yari","year":"2020","journal-title":"Eur J Clin Nutr"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1871474\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:44:06Z","timestamp":1782452646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1871474\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":83,"alternative-id":["10.3389\/fnut.2026.1871474"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1871474","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1871474"}}